Smith & Nephew plc (LON:SN) Receives Average Recommendation of “Hold” from Brokerages

Shares of Smith & Nephew plc (LON:SN) have been given a consensus recommendation of “Hold” by the eight research firms that are covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is GBX 1,382.62.

Several equities research analysts recently commented on the stock. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 1,350 price target on shares of Smith & Nephew in a research report on Monday. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,760 price objective on shares of Smith & Nephew in a research report on Thursday, May 21st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 1,400 target price on shares of Smith & Nephew in a research note on Thursday, June 11th. UBS Group reaffirmed a “neutral” rating and issued a GBX 1,300 target price on shares of Smith & Nephew in a research report on Tuesday, May 5th. Finally, Berenberg Bank reiterated a “hold” rating and set a GBX 13 price target on shares of Smith & Nephew in a report on Friday, May 1st.

Smith & Nephew Price Performance

Shares of SN opened at GBX 1,126.50 on Friday. The stock has a 50 day moving average price of GBX 1,132.35 and a 200-day moving average price of GBX 1,208. The firm has a market capitalization of £12.35 billion, a PE ratio of 40.56, a price-to-earnings-growth ratio of 0.46 and a beta of 0.67. The company has a debt-to-equity ratio of 62.90, a quick ratio of 0.84 and a current ratio of 2.57.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.